Picture of Guangzhou Baiyunshan Pharmaceutical Holdings Co logo

874 Guangzhou Baiyunshan Pharmaceutical Holdings Co Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedMicro Cap

Annual cashflow statement for Guangzhou Baiyunshan Pharmaceutical Holdings Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
CAS
CAS
CAS
CAS
CAS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital-6,828-7,319-7,096-8,244-7,806
Other Operating Cash Flow
Cash from Operating Activities5855,6736,9994,1043,442
Capital Expenditures-877-1,255-1,384-1,628-1,128
Purchase of Fixed Assets
Other Investing Cash Flow Items-212323-5,869-1,486-4,836
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1,088-932-7,253-3,115-5,964
Financing Cash Flow Items-29.9-397-8.9-619-319
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities1,439-1,49445.9-1,978-1,006
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash9323,248-209-981-3,521